메뉴 건너뛰기




Volumn 49, Issue 21, 2008, Pages 3409-3412

Corrigendum to "Enantioselective synthesis of cyclopentyltetrahydrofuran (Cp-THF), an important high-affinity P2-ligand for HIV-1 protease inhibitors". [Tetrahedron Lett. 49 (2008) 3409] (DOI:10.1016/j.tetlet.2008.03.116);Enantioselective synthesis of cyclopentyltetrahydrofuran (Cp-THF), an important high-affinity P2-ligand for HIV-1 protease inhibitors

Author keywords

[No Author keywords available]

Indexed keywords

2 OXABICYCLO[3.3.0]OCT 6 EN 3 ONE; 5 HYDROXY HEXAHYDROCYCLOPENTA[B]FURAN; BICYCLO COMPOUND; CYCLOPENTYLTETRAHYDROFURAN; FURAN DERIVATIVE; GRL 06579A; PROTEINASE INHIBITOR; TETRAHYDROFURAN DERIVATIVE;

EID: 42649092534     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2008.08.053     Document Type: Erratum
Times cited : (14)

References (15)
  • 1
    • 85120275634 scopus 로고    scopus 로고
    • United Nations. 2004, Report on the global HIV/AIDS Epidemic: 4th global report; UN: New York, 2004.
  • 6
    • 85120241336 scopus 로고    scopus 로고
    • On June 23, 2006, FDA approved new HIV treatment for patients who do not respond to existing drugs. Please see http://www.fda.gov/bbs/topics/NEWS/2006/NEW01395.htm .


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.